Second Annual Symposium Highlights

On Tuesday, February 27, 2018, the second annual symposium was held.  The symposium featured distinguished scientists and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.  The following list highlights featured talks:

  • “Impressions of the New NCI Director”
    Norman E. “Ned” Sharpless, MD
    Director, National Cancer Institute
  • “Things I Learned at Washington University and Industry about Drug Discovery and Development”
    Philip Needleman, PhD
    Professor & Chair Emeritus, Department of Pharmacology
  • “Leveraging Neoantigen Discovery in Glioblastoma”
    Gavin Dunn, MD, PhD
    Assistant Professor of Neurological Surgery, Pathology & Immunology
    Bursky Scholar
  • “One in a Billion: Diagnosis and Treatment of Rare Pediatric Immune Diseases”
    Megan Cooper, MD, PhD
    Assistant Professor of Pediatrics, Pathology & Immunology
  • “From Autoimmunity to Zika: Understanding Links between Cell-Intrinsic Innate Immunity, Viruses and Autoimmunity”
    Jonathan Miner, MD, PhD
    Assistant Professor of Medicine, Molecular Microbiology, Pathology & Immunology
  • Robert Schreiber, PhD, left, and Andrew Bursky
  • Andrew Bursky, left, and Robert Schreiber, PhD, enjoy a moment during the welcome to The Burksy Center at Washington University 2nd Annual Symposium
  • Robert Schreiber, PhD
  • Emil R. Unanue, MD
  • Maxim Artyomov, PhD, center, is awarded the Emil R. Unanue Award by Emil R. Unanue, MD, left, and Andrew Bursky, right
  • NCI Director Norman E. "Ned" Sharpless, MD, gives a keynote speech "Impressions of the New NCI Director"
  • NCI Director Norman E. "Ned" Sharpless, MD, gives a keynote speech "Impressions of the New NCI Director"
  • Audience members
  • Audience members
  • Philip Needleman, PhD
  • Vicky Fraser, MD, head of the Department of Medicine, listens to the lectures
  • Philip Needleman, PhD, gives a keynote speech "Things I Learned at Washington University and Industry about Drug Discovery and Development"
  • Andrew and Jane Bursky
  • Siteman Cancer Center Director Timothy Eberlein, left, Andrew Bursky, NCI Director Norman E. "Ned" Sharpless, MD, and Robert Schreiber, PhD
  • Dennis Hallahan, MD, Chairman of the Department of Radiation Oncology, left, Timothy Eberlein, MD, Director of Siteman Cancer Center, NCI Director Norman E. "Ned" Sharpless, MD, and Robert Schreiber, PhD, talk during a break.
  • Dennis Hallahan, MD, Chairman of the Department of Radiation Oncology, left, Timothy Eberlein, MD, Director of Siteman Cancer Center, NCI Director Norman E. "Ned" Sharpless, MD, and Robert Schreiber, PhD, talk during a break.
  • Gavin Dunn, MD, PhD, gives his talk "Leveraging Neoantigen Discovery in Glioblastoma"
  • Gavin Dunn, MD, PhD, gives his talk "Leveraging Neoantigen Discovery in Glioblastoma"
  • Megan Cooper, MD, PhD, gives her talk "One in a Billion: Diagnosis and Treatment of Rare Pediatric Immune Diseases"
  • Megan Cooper, MD, PhD, gives her talk "One in a Billion: Diagnosis and Treatment of Rare Pediatric Immune Diseases"
  • Jonathan Miner, MD, PhD gives his talk "From Autoimmunity to Zika: Understanding Links between Cell-Intrinsic Innate Immunity, Viruses and Autoimmunity"
  • Jonathan Miner, MD, PhD gives his talk "From Autoimmunity to Zika: Understanding Links between Cell-Intrinsic Innate Immunity, Viruses and Autoimmunity"
  • John DiPersio, MD, PhD
  • Dean David Perlmutter, foreground, and Provost Holden Thorp
  • NCI Director Norman E. "Ned" Sharpless, MD, left, talks with Siteman Cancer Center Director Timothy Eberlein, MD, before the The Burksy Center at Washington University 2nd Annual Symposium
  • NCI Director Norman E. "Ned" Sharpless, MD, Clay Thorp, Provost Holden Thorp and Dean David Perlmutter
  • Timothy Eberlein, MD, Director of Siteman Cancer Center, left, NCI Director Norman E. "Ned" Sharpless, MD, Provost Holden Thorp, and Dean David Perlmutter